To be eligible, participants had to be between 25 and 40 years of age, to be healthy as per site physician medical assessment, to be working for 812 h per day, and to have a body mass index (BMI) between 18.5 and 27.5 kg/m 2
doi: 10.1074/jbc.M500978200 48 YinWRomeoSChangSGrishinNVHobbsHHCohenJC
What this means in practice: a prospective patient can complete intake, pay the program fee, and still be determined medically ineligible by the clinician at Stage 2
Its authors found that use of semaglutide reduced: deaths from causes related to cardiovascular disease by 17% hospitalizations for heart failure by 76% non-fatal myocardial infarction (heart attack) by 24% the need for coronary revascularization by 24% strokes in people with diabetes by 35% deaths from any cause by 21%
Some of the strongest early results are in alcohol-use disorder, which makes sense, as these drugs decrease caloric intake and alcohol carries calories
Any peptide therapy at Moonshot Medical is individualized and provided only under medical supervision after an in-person evaluation